Advertisement
Advertisement
HYPR
Hyperfine, Inc. Class A Common Stock
0.74
USDSponsored
-0.04
-5.23%
Oct 29, 15:59 UTC -4
Closed
Pre-Market
0.74
-0.01
-1.02%
Hyperfine, Inc. Class A Common Stock (HYPR) Earnings
HYPR Earnings Reports
Positive Surprise Ratio
HYPR beat 12 of 18 last estimates.
67%
Next Report
Date of Next Report
Nov 09, 2026
Estimate for Q3 26 (Revenue/ EPS)
$5.56M
/-$0.08
Implied change from Q2 26 (Revenue/ EPS)
+42.48%
/-11.11%
Implied change from Q3 25 (Revenue/ EPS)
+61.84%
/-27.27%
Hyperfine, Inc. Class A Common Stock earnings per share and revenue
On Aug 06, 2026, HYPR reported earnings of -0.09 USD per share (EPS) for Q2 26, beating the estimate of -0.09 USD, resulting in a 1.96% surprise. Revenue reached 3.90 million, compared to an expected 4.23 million, with a -7.62% difference. The market reacted with a -2.75% price change (close before vs. close after earnings).
Looking ahead to Q3 26, -- analysts forecast an EPS of -0.08 USD, with revenue projected to reach 5.56 million USD, implying an decrease of -11.11% EPS, and increase of 42.48% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Alphatec Holdings, Inc.
Report Date
Oct 29, 2026 For Q3 26
Estimate
$0.09
Actual
$0.09
Surprise
-6.83%
Beta Bionics, Inc. Common Stock
Report Date
Oct 27, 2026 For Q3 26
Estimate
-$0.53
Actual
-$0.52
Surprise
+2.73%
Integra LifeSciences Holdings
Report Date
Oct 21, 2026 For Q3 26
Estimate
$0.57
Actual
$0.59
Surprise
+3.04%
OrthoPediatrics Corp. Common Stock
Report Date
Oct 27, 2026 For Q3 26
Estimate
-$0.21
Actual
-$0.23
Surprise
-4.88%
ClearPoint Neuro, Inc. Common Stock
Report Date
Oct 28, 2026 For Q3 26
Estimate
-$0.32
Actual
-$0.24
Surprise
+25.30%
Thermo Fisher Scientific, Inc.
Report Date
Oct 21, 2026 For Q3 26
Estimate
$6.46
Actual
$6.68
Surprise
+3.29%
Intuitive Surgical Inc.
Report Date
Oct 20, 2026 For Q3 26
Estimate
$2.69
Actual
$3.00
Surprise
+11.29%
IQVIA Holdings Inc.
Report Date
Oct 27, 2026 For Q3 26
Estimate
$3.30
Actual
$3.34
Surprise
+0.97%
Glaukos Corporation
Report Date
Oct 28, 2026 For Q3 26
Estimate
-$0.09
Actual
$0.47
Surprise
+611.98%
Axogen, Inc. Common Stock
Report Date
Oct 28, 2026 For Q3 26
Estimate
$0.14
Actual
$0.21
Surprise
+47.06%
FAQ
What were Hyperfine, Inc. Class A Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Hyperfine, Inc. Class A Common Stock reported EPS of -$0.09, beating estimates by 1.96%, and revenue of $3.90M, -7.62% below expectations.
How did the market react to Hyperfine, Inc. Class A Common Stock's Q2 2026 earnings?
The stock price moved down -2.75%, changed from $0.98 before the earnings release to $0.95 the day after.
When is Hyperfine, Inc. Class A Common Stock expected to report next?
The next earning report is scheduled for Nov 09, 2026.
What are the forecasts for Hyperfine, Inc. Class A Common Stock's next earnings report?
Based on --
analysts, Hyperfine, Inc. Class A Common Stock is expected to report EPS of -$0.08 and revenue of $5.56M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.